nodes	percent_of_prediction	percent_of_DWPC	metapath
Liothyronine—SLCO4C1—Methotrexate—systemic scleroderma	0.139	0.149	CbGbCtD
Liothyronine—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.136	0.145	CbGbCtD
Liothyronine—SLCO1C1—Methotrexate—systemic scleroderma	0.0978	0.104	CbGbCtD
Liothyronine—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0793	0.0846	CbGbCtD
Liothyronine—SLCO1A2—Prednisone—systemic scleroderma	0.0672	0.0717	CbGbCtD
Liothyronine—ALB—Captopril—systemic scleroderma	0.0552	0.0589	CbGbCtD
Liothyronine—SLCO1B3—Methotrexate—systemic scleroderma	0.0546	0.0583	CbGbCtD
Liothyronine—ALB—Mycophenolate mofetil—systemic scleroderma	0.0434	0.0463	CbGbCtD
Liothyronine—ABCB1—Lisinopril—systemic scleroderma	0.0386	0.0411	CbGbCtD
Liothyronine—ALB—Prednisone—systemic scleroderma	0.0347	0.0371	CbGbCtD
Liothyronine—SLCO1A2—Methotrexate—systemic scleroderma	0.0337	0.036	CbGbCtD
Liothyronine—SLCO1B1—Methotrexate—systemic scleroderma	0.0318	0.0339	CbGbCtD
Liothyronine—SLC22A8—Methotrexate—systemic scleroderma	0.0294	0.0313	CbGbCtD
Liothyronine—ABCB1—Captopril—systemic scleroderma	0.0289	0.0308	CbGbCtD
Liothyronine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0227	0.0242	CbGbCtD
Liothyronine—ABCB1—Prednisone—systemic scleroderma	0.0182	0.0194	CbGbCtD
Liothyronine—ALB—Methotrexate—systemic scleroderma	0.0174	0.0186	CbGbCtD
Liothyronine—ABCB1—Methotrexate—systemic scleroderma	0.00911	0.00972	CbGbCtD
Liothyronine—SLC7A5—Mycophenolic acid—Mycophenolate mofetil—systemic scleroderma	0.00554	0.829	CbGdCrCtD
Liothyronine—THRA—connective tissue—systemic scleroderma	0.00182	0.071	CbGeAlD
Liothyronine—SLC7A5—connective tissue—systemic scleroderma	0.00139	0.0541	CbGeAlD
Liothyronine—TTR—connective tissue—systemic scleroderma	0.00135	0.0527	CbGeAlD
Liothyronine—SLC7A5—smooth muscle tissue—systemic scleroderma	0.00127	0.0495	CbGeAlD
Liothyronine—Angina pectoris—Pentoxifylline—systemic scleroderma	0.00125	0.0444	CcSEcCtD
Liothyronine—SLC7A5—skin of body—systemic scleroderma	0.00125	0.0489	CbGeAlD
Liothyronine—THRA—tendon—systemic scleroderma	0.00125	0.0488	CbGeAlD
Liothyronine—THRB—tendon—systemic scleroderma	0.00125	0.0488	CbGeAlD
Liothyronine—SLC10A1—digestive system—systemic scleroderma	0.00116	0.0453	CbGeAlD
Liothyronine—SLCO4C1—lung—systemic scleroderma	0.00114	0.0446	CbGeAlD
Liothyronine—SLCO1B3—lung—systemic scleroderma	0.00111	0.0434	CbGeAlD
Liothyronine—THRB—lung—systemic scleroderma	0.0011	0.0428	CbGeAlD
Liothyronine—THRA—lung—systemic scleroderma	0.0011	0.0428	CbGeAlD
Liothyronine—Phlebitis—Mycophenolic acid—systemic scleroderma	0.00103	0.0364	CcSEcCtD
Liothyronine—SLC7A5—digestive system—systemic scleroderma	0.001	0.0391	CbGeAlD
Liothyronine—Cardiac failure congestive—Mycophenolic acid—systemic scleroderma	0.000979	0.0346	CcSEcCtD
Liothyronine—TTR—digestive system—systemic scleroderma	0.000976	0.0381	CbGeAlD
Liothyronine—SLC7A5—tendon—systemic scleroderma	0.000953	0.0372	CbGeAlD
Liothyronine—Angina pectoris—Captopril—systemic scleroderma	0.00095	0.0336	CcSEcCtD
Liothyronine—Arrhythmia—Pentoxifylline—systemic scleroderma	0.000921	0.0326	CcSEcCtD
Liothyronine—SLCO4A1—digestive system—systemic scleroderma	0.000875	0.0341	CbGeAlD
Liothyronine—SLC7A5—lung—systemic scleroderma	0.000837	0.0327	CbGeAlD
Liothyronine—TTR—lung—systemic scleroderma	0.000815	0.0318	CbGeAlD
Liothyronine—Phlebitis—Mycophenolate mofetil—systemic scleroderma	0.000813	0.0288	CcSEcCtD
Liothyronine—Angina pectoris—Leflunomide—systemic scleroderma	0.000783	0.0277	CcSEcCtD
Liothyronine—Hypertension—Pentoxifylline—systemic scleroderma	0.000775	0.0274	CcSEcCtD
Liothyronine—Cardiac failure congestive—Mycophenolate mofetil—systemic scleroderma	0.000772	0.0273	CcSEcCtD
Liothyronine—SLCO1B1—digestive system—systemic scleroderma	0.00077	0.03	CbGeAlD
Liothyronine—Angina pectoris—Mycophenolic acid—systemic scleroderma	0.000747	0.0264	CcSEcCtD
Liothyronine—SLC7A5—Desoximetasone—Mometasone—systemic scleroderma	0.000742	0.111	CbGdCrCtD
Liothyronine—SLCO4A1—lung—systemic scleroderma	0.000731	0.0285	CbGeAlD
Liothyronine—SLC16A10—tendon—systemic scleroderma	0.00073	0.0285	CbGeAlD
Liothyronine—Tachycardia—Pentoxifylline—systemic scleroderma	0.000715	0.0253	CcSEcCtD
Liothyronine—Hypotension—Pentoxifylline—systemic scleroderma	0.000684	0.0242	CcSEcCtD
Liothyronine—Angina pectoris—Lisinopril—systemic scleroderma	0.000673	0.0238	CcSEcCtD
Liothyronine—SLC16A10—lung—systemic scleroderma	0.000641	0.025	CbGeAlD
Liothyronine—SLCO1A2—digestive system—systemic scleroderma	0.000626	0.0245	CbGeAlD
Liothyronine—Arrhythmia—Azathioprine—systemic scleroderma	0.000609	0.0215	CcSEcCtD
Liothyronine—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.000607	0.0215	CcSEcCtD
Liothyronine—Myocardial infarction—Lisinopril—systemic scleroderma	0.000604	0.0214	CcSEcCtD
Liothyronine—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.00059	0.0209	CcSEcCtD
Liothyronine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000579	0.0205	CcSEcCtD
Liothyronine—Arrhythmia—Leflunomide—systemic scleroderma	0.000575	0.0203	CcSEcCtD
Liothyronine—ABCB1—blood vessel—systemic scleroderma	0.000567	0.0221	CbGeAlD
Liothyronine—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.000549	0.0194	CcSEcCtD
Liothyronine—Tachycardia—Captopril—systemic scleroderma	0.000542	0.0192	CcSEcCtD
Liothyronine—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.000532	0.0188	CcSEcCtD
Liothyronine—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.000529	0.0187	CcSEcCtD
Liothyronine—Cardiac failure congestive—Prednisone—systemic scleroderma	0.000524	0.0185	CcSEcCtD
Liothyronine—SLCO1A2—lung—systemic scleroderma	0.000523	0.0204	CbGeAlD
Liothyronine—Hypotension—Captopril—systemic scleroderma	0.000518	0.0183	CcSEcCtD
Liothyronine—Body temperature increased—Mometasone—systemic scleroderma	0.000499	0.0177	CcSEcCtD
Liothyronine—Arrhythmia—Lisinopril—systemic scleroderma	0.000494	0.0175	CcSEcCtD
Liothyronine—Hypertension—Leflunomide—systemic scleroderma	0.000484	0.0171	CcSEcCtD
Liothyronine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000462	0.0163	CcSEcCtD
Liothyronine—Hypotension—Azathioprine—systemic scleroderma	0.000452	0.016	CcSEcCtD
Liothyronine—Tachycardia—Leflunomide—systemic scleroderma	0.000446	0.0158	CcSEcCtD
Liothyronine—Body temperature increased—Captopril—systemic scleroderma	0.000439	0.0155	CcSEcCtD
Liothyronine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000433	0.0153	CcSEcCtD
Liothyronine—Hypotension—Leflunomide—systemic scleroderma	0.000427	0.0151	CcSEcCtD
Liothyronine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000426	0.0151	CcSEcCtD
Liothyronine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000408	0.0144	CcSEcCtD
Liothyronine—SLC7A5—Desoximetasone—Prednisone—systemic scleroderma	0.000404	0.0605	CbGdCrCtD
Liothyronine—Tachycardia—Lisinopril—systemic scleroderma	0.000384	0.0136	CcSEcCtD
Liothyronine—Body temperature increased—Azathioprine—systemic scleroderma	0.000383	0.0135	CcSEcCtD
Liothyronine—Hypotension—Lisinopril—systemic scleroderma	0.000367	0.013	CcSEcCtD
Liothyronine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000364	0.0129	CcSEcCtD
Liothyronine—Body temperature increased—Leflunomide—systemic scleroderma	0.000362	0.0128	CcSEcCtD
Liothyronine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000361	0.0128	CcSEcCtD
Liothyronine—Myocardial infarction—Prednisone—systemic scleroderma	0.000359	0.0127	CcSEcCtD
Liothyronine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000345	0.0122	CcSEcCtD
Liothyronine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000336	0.0119	CcSEcCtD
Liothyronine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000322	0.0114	CcSEcCtD
Liothyronine—Body temperature increased—Lisinopril—systemic scleroderma	0.000311	0.011	CcSEcCtD
Liothyronine—Arrhythmia—Prednisone—systemic scleroderma	0.000293	0.0104	CcSEcCtD
Liothyronine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000272	0.00963	CcSEcCtD
Liothyronine—Hypertension—Prednisone—systemic scleroderma	0.000247	0.00873	CcSEcCtD
Liothyronine—Tachycardia—Prednisone—systemic scleroderma	0.000228	0.00806	CcSEcCtD
Liothyronine—ABCB1—digestive system—systemic scleroderma	0.00021	0.00819	CbGeAlD
Liothyronine—Body temperature increased—Prednisone—systemic scleroderma	0.000184	0.00652	CcSEcCtD
Liothyronine—Hypotension—Methotrexate—systemic scleroderma	0.000182	0.00645	CcSEcCtD
Liothyronine—ABCB1—lung—systemic scleroderma	0.000175	0.00684	CbGeAlD
Liothyronine—Body temperature increased—Methotrexate—systemic scleroderma	0.000154	0.00545	CcSEcCtD
Liothyronine—TTR—Retinoid metabolism and transport—HSPG2—systemic scleroderma	0.00013	0.0594	CbGpPWpGaD
Liothyronine—TTR—Non-integrin membrane-ECM interactions—HSPG2—systemic scleroderma	0.000128	0.0583	CbGpPWpGaD
Liothyronine—SLC7A5—Basigin interactions—MMP1—systemic scleroderma	0.000105	0.0479	CbGpPWpGaD
Liothyronine—TTR—Amyloids—TGFBI—systemic scleroderma	9.55e-05	0.0436	CbGpPWpGaD
Liothyronine—SLC7A5—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	8.71e-05	0.0398	CbGpPWpGaD
Liothyronine—TTR—Amyloids—HSPG2—systemic scleroderma	7.62e-05	0.0348	CbGpPWpGaD
Liothyronine—SLC7A5—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	6.96e-05	0.0318	CbGpPWpGaD
Liothyronine—TTR—Diseases associated with visual transduction—HSPG2—systemic scleroderma	6.64e-05	0.0303	CbGpPWpGaD
Liothyronine—THRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic scleroderma	5.73e-05	0.0262	CbGpPWpGaD
Liothyronine—THRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic scleroderma	5.73e-05	0.0262	CbGpPWpGaD
Liothyronine—THRB—SIDS Susceptibility Pathways—IL13—systemic scleroderma	5.36e-05	0.0245	CbGpPWpGaD
Liothyronine—TTR—Extracellular matrix organization—FBN1—systemic scleroderma	4.19e-05	0.0191	CbGpPWpGaD
Liothyronine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	3.97e-05	0.0181	CbGpPWpGaD
Liothyronine—ALB—Lipoprotein metabolism—HSPG2—systemic scleroderma	3.97e-05	0.0181	CbGpPWpGaD
Liothyronine—THRA—Generic Transcription Pathway—SMAD7—systemic scleroderma	3.63e-05	0.0166	CbGpPWpGaD
Liothyronine—THRB—Generic Transcription Pathway—SMAD7—systemic scleroderma	3.63e-05	0.0166	CbGpPWpGaD
Liothyronine—SLC7A5—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	3.49e-05	0.0159	CbGpPWpGaD
Liothyronine—THRA—Endochondral Ossification—MMP9—systemic scleroderma	3.38e-05	0.0154	CbGpPWpGaD
Liothyronine—THRB—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	3.37e-05	0.0154	CbGpPWpGaD
Liothyronine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—systemic scleroderma	3.09e-05	0.0141	CbGpPWpGaD
Liothyronine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	3.09e-05	0.0141	CbGpPWpGaD
Liothyronine—TTR—Extracellular matrix organization—COL1A2—systemic scleroderma	2.93e-05	0.0134	CbGpPWpGaD
Liothyronine—TTR—Extracellular matrix organization—HSPG2—systemic scleroderma	2.93e-05	0.0134	CbGpPWpGaD
Liothyronine—THRA—Endochondral Ossification—TGFB1—systemic scleroderma	2.79e-05	0.0127	CbGpPWpGaD
Liothyronine—TTR—Non-integrin membrane-ECM interactions—TGFB1—systemic scleroderma	2.78e-05	0.0127	CbGpPWpGaD
Liothyronine—TTR—Extracellular matrix organization—ITGAM—systemic scleroderma	2.66e-05	0.0122	CbGpPWpGaD
Liothyronine—ALB—Lipid and lipoprotein metabolism—HSPG2—systemic scleroderma	2.64e-05	0.012	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—SELP—systemic scleroderma	2.36e-05	0.0108	CbGpPWpGaD
Liothyronine—ALB—Folate Metabolism—CSF1—systemic scleroderma	2.31e-05	0.0106	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—RHOB—systemic scleroderma	2.2e-05	0.0101	CbGpPWpGaD
Liothyronine—ALB—Platelet degranulation—SELP—systemic scleroderma	2.06e-05	0.00939	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—CSK—systemic scleroderma	2.01e-05	0.00917	CbGpPWpGaD
Liothyronine—THRA—Generic Transcription Pathway—CTGF—systemic scleroderma	2.01e-05	0.00916	CbGpPWpGaD
Liothyronine—THRB—Generic Transcription Pathway—CTGF—systemic scleroderma	2.01e-05	0.00916	CbGpPWpGaD
Liothyronine—ALB—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	1.96e-05	0.00895	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—ITGAM—systemic scleroderma	1.89e-05	0.00862	CbGpPWpGaD
Liothyronine—THRB—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	1.76e-05	0.00803	CbGpPWpGaD
Liothyronine—THRA—Gene Expression—SMAD7—systemic scleroderma	1.75e-05	0.00798	CbGpPWpGaD
Liothyronine—THRB—Gene Expression—SMAD7—systemic scleroderma	1.75e-05	0.00798	CbGpPWpGaD
Liothyronine—THRB—Gene Expression—TNFSF13—systemic scleroderma	1.62e-05	0.00742	CbGpPWpGaD
Liothyronine—THRA—Gene Expression—TNFSF13—systemic scleroderma	1.62e-05	0.00742	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.57e-05	0.00716	CbGpPWpGaD
Liothyronine—ABCB1—Allograft Rejection—IL13—systemic scleroderma	1.37e-05	0.00626	CbGpPWpGaD
Liothyronine—TTR—Extracellular matrix organization—MMP1—systemic scleroderma	1.33e-05	0.00609	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	1.22e-05	0.00556	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.19e-05	0.00543	CbGpPWpGaD
Liothyronine—TTR—Disease—SMAD7—systemic scleroderma	1.16e-05	0.00528	CbGpPWpGaD
Liothyronine—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	1.1e-05	0.00504	CbGpPWpGaD
Liothyronine—TTR—Disease—TGFBI—systemic scleroderma	1.06e-05	0.00483	CbGpPWpGaD
Liothyronine—TTR—Extracellular matrix organization—MMP2—systemic scleroderma	1.03e-05	0.00471	CbGpPWpGaD
Liothyronine—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	1e-05	0.00458	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	9.82e-06	0.00448	CbGpPWpGaD
Liothyronine—THRA—Gene Expression—CTGF—systemic scleroderma	9.66e-06	0.00441	CbGpPWpGaD
Liothyronine—THRB—Gene Expression—CTGF—systemic scleroderma	9.66e-06	0.00441	CbGpPWpGaD
Liothyronine—ALB—Vitamin B12 Metabolism—CCL2—systemic scleroderma	9.61e-06	0.00439	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—MMP1—systemic scleroderma	9.46e-06	0.00432	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	9.12e-06	0.00417	CbGpPWpGaD
Liothyronine—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	9.08e-06	0.00415	CbGpPWpGaD
Liothyronine—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	8.63e-06	0.00394	CbGpPWpGaD
Liothyronine—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	8.58e-06	0.00392	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	8.52e-06	0.00389	CbGpPWpGaD
Liothyronine—TTR—Disease—HSPG2—systemic scleroderma	8.43e-06	0.00385	CbGpPWpGaD
Liothyronine—TTR—Disease—CSK—systemic scleroderma	8.14e-06	0.00372	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—SMAD7—systemic scleroderma	8.09e-06	0.0037	CbGpPWpGaD
Liothyronine—ALB—Folate Metabolism—CCL2—systemic scleroderma	7.82e-06	0.00357	CbGpPWpGaD
Liothyronine—TTR—Extracellular matrix organization—MMP9—systemic scleroderma	7.76e-06	0.00354	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	7.76e-06	0.00354	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	7.71e-06	0.00352	CbGpPWpGaD
Liothyronine—TTR—Disease—CD247—systemic scleroderma	7.66e-06	0.0035	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	7.44e-06	0.0034	CbGpPWpGaD
Liothyronine—ALB—Vitamin B12 Metabolism—IL1B—systemic scleroderma	7.29e-06	0.00333	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—HSPG2—systemic scleroderma	6.98e-06	0.00319	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—NOS3—systemic scleroderma	6.86e-06	0.00313	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	6.6e-06	0.00301	CbGpPWpGaD
Liothyronine—TTR—Extracellular matrix organization—TGFB1—systemic scleroderma	6.39e-06	0.00292	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—RHOB—systemic scleroderma	6.26e-06	0.00286	CbGpPWpGaD
Liothyronine—ALB—Selenium Micronutrient Network—CCL2—systemic scleroderma	6.21e-06	0.00284	CbGpPWpGaD
Liothyronine—ALB—Folate Metabolism—IL1B—systemic scleroderma	5.93e-06	0.00271	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—HSPG2—systemic scleroderma	5.9e-06	0.0027	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	5.85e-06	0.00267	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CSK—systemic scleroderma	5.7e-06	0.0026	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—CTGF—systemic scleroderma	5.29e-06	0.00242	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	5e-06	0.00228	CbGpPWpGaD
Liothyronine—ALB—Selenium Micronutrient Network—IL1B—systemic scleroderma	4.71e-06	0.00215	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—SELP—systemic scleroderma	4.7e-06	0.00215	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—TGFB1—systemic scleroderma	4.53e-06	0.00207	CbGpPWpGaD
Liothyronine—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	4.5e-06	0.00205	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—RHOB—systemic scleroderma	4.39e-06	0.00201	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—HSPG2—systemic scleroderma	4.37e-06	0.002	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—CSK—systemic scleroderma	4e-06	0.00183	CbGpPWpGaD
Liothyronine—ALB—Platelet degranulation—TGFB1—systemic scleroderma	3.95e-06	0.0018	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.77e-06	0.00172	CbGpPWpGaD
Liothyronine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	3.76e-06	0.00172	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—ITGAM—systemic scleroderma	3.76e-06	0.00172	CbGpPWpGaD
Liothyronine—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	3.5e-06	0.0016	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—HSPG2—systemic scleroderma	3.44e-06	0.00157	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—CTGF—systemic scleroderma	3.31e-06	0.00151	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—EDN1—systemic scleroderma	3.2e-06	0.00146	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—HSPG2—systemic scleroderma	2.94e-06	0.00134	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.86e-06	0.0013	CbGpPWpGaD
Liothyronine—TTR—Disease—NOS3—systemic scleroderma	2.78e-06	0.00127	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—CTGF—systemic scleroderma	2.6e-06	0.00119	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—NOS3—systemic scleroderma	2.3e-06	0.00105	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—CTGF—systemic scleroderma	2.23e-06	0.00102	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CCL2—systemic scleroderma	2.19e-06	0.000998	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—NOS3—systemic scleroderma	1.95e-06	0.00089	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—MMP1—systemic scleroderma	1.88e-06	0.000861	CbGpPWpGaD
Liothyronine—TTR—Disease—TGFB1—systemic scleroderma	1.84e-06	0.00084	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	1.75e-06	0.0008	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.73e-06	0.000788	CbGpPWpGaD
Liothyronine—ALB—Metabolism—HSPG2—systemic scleroderma	1.68e-06	0.000767	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MMP9—systemic scleroderma	1.56e-06	0.000714	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—HSPG2—systemic scleroderma	1.47e-06	0.000672	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—NOS3—systemic scleroderma	1.44e-06	0.000659	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—NOS3—systemic scleroderma	1.37e-06	0.000624	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—TGFB1—systemic scleroderma	1.29e-06	0.000588	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CTGF—systemic scleroderma	1.27e-06	0.000581	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—NOS3—systemic scleroderma	1.13e-06	0.000518	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CTGF—systemic scleroderma	1.11e-06	0.000509	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—NOS3—systemic scleroderma	9.69e-07	0.000443	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—TGFB1—systemic scleroderma	9.03e-07	0.000412	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NOS3—systemic scleroderma	5.54e-07	0.000253	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NOS3—systemic scleroderma	4.85e-07	0.000222	CbGpPWpGaD
